Authors:
ECKHARDT SG
BURRIS HA
ECKARDT JR
WEISS G
RODRIGUEZ G
ROTHENBERG M
RINALDI D
BARRINGTON R
KUHN JG
MASUO K
SUDO K
ATSUMI R
OGUMA T
HIGASHI L
FIELDS S
SMETZER L
VONHOFF DD
Citation: Sg. Eckhardt et al., A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THE ANGIOGENESIS INHIBITOR, TECOGALAN SODIUM, Annals of oncology, 7(5), 1996, pp. 491-496
Citation: R. Atsumi et al., PHARMACOKINETICS OF ,7]-INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H-DIONE], AN ACTIVE METABOLITE OF IRINOTECAN, AFTER A SINGLE INTRAVENOUS DOSING OF C-14 SN-38 TO RATS()), Biological & pharmaceutical bulletin, 18(8), 1995, pp. 1114-1119
Citation: R. Atsumi et al., METABOLISM OF IRINOTECAN TO SN-38 IN A TISSUE-ISOLATED TUMOR-MODEL, Biological & pharmaceutical bulletin, 18(7), 1995, pp. 1024-1026
Authors:
YACHI K
KIKUCHI H
SUZUKI N
ATSUMI R
AONUMA M
KAWATO Y
Citation: K. Yachi et al., PHARMACEUTICAL AND BIOLOGICAL PROPERTIES OF DOXORUBICIN ENCAPSULATED IN LIPOSOMES (L-ADM) - THE EFFECT OF REPEATED ADMINISTRATION ON THE SYSTEMIC PHAGOCYTIC-ACTIVITY AND PHARMACOKINETICS, Biopharmaceutics & drug disposition, 16(8), 1995, pp. 653-667
Authors:
SATOH T
HOSOKAWA M
ATSUMI R
SUZUKI W
HAKUSUI H
NAGAI E
Citation: T. Satoh et al., METABOLIC-ACTIVATION OF CPT-11, -PIPERIDINO)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN, A NOVEL ANTITUMOR AGENT, BY CARBOXYLESTERASE, Biological & pharmaceutical bulletin, 17(5), 1994, pp. 662-664